Sylviane Muller#
| Membership Number: | 5426 |
| Membership type: | ORDINARY |
| Section: | CHEMICAL SCIENCES |
| Elected: | 2020 |
| Main Country of Residence: | FRANCE |
| ORCID: | 0000-0002-0481-0620 |
Present and Previous Positions
- 2021 - 2028 Director of the Strasbourg Institute for drug development and discovery (IMS), Strasbourg, France
- 2018 August Emeritus Research Director CNRS
- 2016 - 2017 Director Institut de Biologie Moléculaire et Cellulaire (IBMC), CNRS, Strasbourg, France
- 2013 - 2016 Deputy Director IBMC, Strasbourg, France
- 2012 - 2013 Deputy Director of the Biological Sciences Institute (INSB) CNRS Headquarters, Paris, France
- 2012 Professor at the Institute of Advanced Studies of the Strasbourg University (USIAS) Chair Therapeutic immunology
- 2011 - 2020 Director of the Drug discovery Center for cancer and inflammation Medalis awarded 'Laboratory of Excellence’
- 2008 - 2011 Scientific representative for valorization and transfer of technology, INSB, CNRS Headquarters, Paris, France
- 2001 - 2017 Director of the CNRS Unit Therapeutic immunology & chemistry, IBMC, Strasbourg , France
- 1981 - 2018 Researcher in CNRS (Distinguished Class Research Director 2009-2018)
Fields of Scholarship
- Proteins: post-translational modifications, misfolding
- Mutidisciplinary field of research and expertise: Organic synthesis and immunology
- Peptides: chemistry, immunochemistry
- Immunopathology: autoimmunity, peptide-based synthetic vaccines
- Nanomedicine: nanovectors, biodelivery, safety
- Cellular immunology: mechanisms of the death /survival balance (apoptosis, autophagy), lymphocytes (signaling)
- Therapeutic immunology and chemistry: development of molecules that target pathological pathways, peptide drug candidates
- Clinical trials: animal models, human
Honours and Awards
- 2020 Member of the European Academy of Sciences
- 2017 Finalist of the European Inventor Award (category Research)
- 2017 Innovation price from the Fondation Arthritis
- 2016 Officier de l’Ordre National du Mérite
- 2016 Léon Velluz Prize from the French Academy of Sciences
- 2015 Paul-Ehrlich Award from the French Society of therapeutic chemistry and Janssen research & development (Johnson & Johnson)
- 2015 CNRS Innovation Award
- 2010 Chevalier de l’Ordre de la Légion d’Honneur
- 2009 CNRS Silver Medal
